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http://dx.doi.org/10.1016/j.jfma.201
0929-6646/Copyright ª 2015, ElsevierStudies of the major signaling pathways have revealed a connection between development,
regeneration, and cancer, highlighting common signaling networks in these processes. The
Hedgehog (Hh) pathway plays a central role in the development of most tissues and organs
in mammals. Hh signaling is also required for tissue homeostasis and regeneration in adults,
while perturbed Hh signaling is associated with human cancers. A fundamental understanding
of Hh signaling will not only enhance our knowledge of how the embryos are patterned but also
provide tools to treat diseases related to aberrant Hh signaling. Studies have yielded a basic
framework of Hh signaling, which establishes the foundation for addressing unresolved issues
of Hh signaling. A detailed characterization of the biochemical interactions between Hh com-
ponents will help explain the production of graded Hh responses required for tissue patterning.
Additional cell biological and genetic studies will offer new insight into the role of Hh signaling
in homeostasis and regeneration. Finally, drugs that are capable of manipulating the Hh
pathway can be used to treat human diseases caused by disrupted Hh signaling. These inves-
tigations will serve as a paradigm for studying signal transduction/integration in homeostasis
and disease, and for translating discovery from bench to bedside.
Copyright ª 2015, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
The Hedgehog (Hh) pathway is one of several major
signaling pathways that control key steps of embryonichave no conflicts of interest
lar Research Institute, Uni-
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Taiwan LLC & Formosan Medicaldevelopment.1e3 Hh signaling also participates in tissue
homeostasis and regeneration4 while perturbation of Hh
signaling is associated with several human cancers.5e7 This
highlights the versatility of conserved signaling pathways in
multiple signaling contexts during the life span of an or-
ganism from embryonic development to postnatal physi-
ology and pathology. Elucidating the molecular mechanisms
of Hh signaling will increase our fundamental understanding
of Hh signaling and serve as a paradigm to illuminate
pathway design and evolution. These studies also hold the
promise to provide tools for detecting and eventually
treating human diseases caused by aberrant Hh signaling.Association. All rights reserved.
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transduction
The basic framework of Hh signaling has been established
through extensive studies in cell-based assays and model
organisms. Hh signaling adopts multiple control steps at
different subcellular locales that engage various regulatory
mechanisms, some of which seem to be unique to Hh
signaling. This important property ensures the production
of graded responses in Hh-responsive cells. Moreover, such
a pathway design enables tight regulation of Hh signaling in
a temporally and spatially specific manner, a key require-
ment for tissue patterning and homeostasis.
Hedgehog ligand biogenesis and release
Among the three mammalian Hh ligands, Sonic hedgehog
(Shh), Indian hedgehog (Ihh), and Desert hedgehog (Dhh),
Shh exhibits the widest tissue expression and is also the
best characterized. Hh proteins elicit dose-dependent re-
sponses and, in several tissues, fulfill the definition of a
classical morphogen, for instance, in the developing neural
tube and the limb. Thus, elucidating the molecular basis of
Hh protein distribution and action will reveal a fundamental
mechanism of tissue patterning (see Fig. 1). The Hh ligand
undergoes proteolytic cleavage to produce an N-terminal
signaling fragment with dual lipid modification.8,9 The
mature form has a cholesterol adduct at its N-terminus and
a palmitoyl moiety at its C-terminus. Cholesterol modifi-
cation is mediated by the C-terminal fragment of the Hh
protein while Skinny hedgehog (Skn/Hhat), an acyl-
transferase, catalyzes the addition of a palmitoyl group.10
Lipid modification enhances local Hh protein levels and
activity but also restricts its long-range distribution.11 The
lipidated Hh ligand is released from Hh-producing cells, a
process that requires the transmembrane protein Dis-
patched (Disp), and the secreted protein SCUBE2, and is
subsequently delivered to Hh-responding cells. Several
models have been proposed for Hh distribution, including a
soluble Hh protein complex,12 a lipoprotein particle,13
exosomes (membrane vesicles), and actin-based special-
ized filopodia (cytonemes).14 An important task in this
active area of research is to uncover the in vivo relevance
of the proposed modes of Hh distribution. This could be
challenging because many of these processes involve ma-
chinery that also functions in other processes and the ma-
chinery that executes each mode of transport has not been
fully characterized. Moreover, whether Hh-producing cells
utilize a unique method or a combination of mechanisms to
distribute its Hh ligand and whether different tissues
preferentially rely on a particular mechanism require
further studies. Finally, it is unclear if these are universal
mechanisms in distributing other signaling molecules.
Hedgehog signal transduction
Hh signaling is initiated through binding of the Hh ligand to
its receptor, Patched 1 (Ptch1), a 12-pass transmembrane
protein with topological similarity to transporters (see
Fig. 2). This process is facilitated by several accessory
proteins, including Boc (bioregional Cdon-binding protein),Cdon (cell-adhesion-molecule-related), and Gas1 (growth
arrest specific 1).15e19 Distinct complexes that are
comprised of Ptch1 and one of its coreceptors have been
reported, indicating the overlapping and distinct functions
of these accessory proteins.20,21 However, the molecular
basis of how Hh coreceptors enhance Hh signaling remains
unknown. Hh binding to Ptch1 relieves Ptch1 repression of
the seven-pass transmembrane protein, Smoothened
(Smo), and triggers a cascade of signaling events down-
stream from Smo.22e24 Lipidated Hh protein has increased
signaling activity and it is unclear how lipid modification
confers such an important property.
Similarly, despite extensive studies, the molecular
mechanisms by which Ptch1 regulates Smo activity remain
an enigma. Because Ptch1 does not directly interact with
Smo,25 it is generally believed that a small molecule (or
molecules) regulated by Ptch1 mediates the interaction
between Ptch and Smo. The identity of the mediator be-
tween Ptch and Smo remains elusive. Such molecules may
not be amenable to genetic manipulations and their dis-
covery would be likely to rely on cell-based assays and
proteomic approaches. Interestingly, oxysterols bind Smo
and promote Smo activity,22e24,26 adding another layer of
regulation to Hh signaling and strengthening a link between
Hh signaling and lipid metabolism. The purported small
molecule mediator of Ptch can possibly influence oxysterols
in addition to inhibiting Smo. As discussed below, mutations
in Ptch1 or Smo underlie several human tumors, and a
mechanistic understanding of how Hh signal is transduced
via Ptch/co-receptor/Smo will have a major impact on our
fundamental understanding of tumor development and
treatment.Control of Hh target gene expression
Three transcription factors, Gli1e3, mediate Hh target
gene expression in the nucleus.27,28 Gli329 and to some
extent Gli230,31 undergo limited proteolysis to generate a
transcriptional repressor that inhibits Hh target gene
expression in the absence of Hh signaling.32 Hh signaling not
only inhibits Gli repressor formation but also promotes the
production of Gli activators (derived from full-length Gli
proteins) to activate nuclear Hh targets. Unlike Gli2/3, Gli1
does not undergo limited proteolysis and only functions as
an activator. Gli1 transcription is induced by Hh signaling
and serves to amplify the Hh signal. Hh target gene
expression is controlled by varying levels and combinations
of Gli activators and repressors in a given tissue, thus
generating Hh outputs appropriate for tissue devel-
opment.29,33e36 The overlapping function of Gli proteins
and the variable expression and requirements of individual
Gli proteins in diverse tissues render predictions of Hh re-
sponses and phenotypes a challenging task.35,37 An impor-
tant question is to identify and characterize Gli targets in
diverse tissues in order to further understand how Hh
signaling controls various aspects of tissue development
and homeostasis.27,38,39 In this regard, significant progress
has been made in the neural tube and the limb. A combi-
nation of chromatin immunoprecipitation sequencing (ChIP-
Seq), transgenesis and modeling has yielded a network of
signaling that serves as a blueprint for further
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Figure 1 Production and secretion of Hedgehog (Hh) protein. The Hh protein is synthesized as an w45kDa precursor, which is
then transported to the endoplasmic reticulum for processing. The Hh protein undergoes autocatalytic cleavage, facilitating the
addition of a cholesterol moiety to its C-terminus. Hh acyltransferase (Hhat) catalyzes the addition of palmitate to the N-terminus.
The processed Hh protein is released from the Hh-producing cell through the action of the 12-pass transmembrane protein, Dis-
patched (Disp) in combination with the soluble protein, Scube2. The Hh protein is delivered to Hh-responsive cells by one of four
possible mechanisms: (a) Hh is transported to the Hh-receiving cell via the cytoneme; (b) the Hh protein is released from the
plasma membrane as a soluble multimer; (c) Hh proteins assemble with lipophorin apolipoproteins to form lipoprotein particles;
(d) Hh proteins are released and delivered through exovesicles.
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proteins and to other tissues would enable a better
description of how a combinatorial use of the three Gli
proteins can produce graded Hh responses.
A key negative regulator in Hh signaling downstream
from Smo is Suppressor of Fused (Sufu).43,44 Sufu controls
the protein levels, activity and distribution of the three Glitranscription factors and Sufu/Gli constitute a major reg-
ulatory hub in Hh signaling downstream from Smo. Sufu can
sequester Gli proteins,45e48 regulate Gli protein levels,49e51
promote the production of Gli repressor and control Gli
protein activity.52,53 This perhaps endows Hh-responsive
cells with the ability to produce complex responses and
offers focal points for integrating inputs. Loss of Sufu leads
Figure 2 Mammalian Hedgehog (Hh) signal transduction. (A) In the absence of Hh ligand, the 12-pass transmembrane protein,
Patched (Ptch), inhibits the activity of the seven-pass transmembrane protein Smoothened (Smo). Suppressor of Fused (Sufu)
sequesters Gli2/3 in the cytosol and perhaps also in other subcellular locales such as the cilium and the nucleus. Phosphorylation of
Gli by the kinases, PKA, CK1 and GSK3b, promotes the formation of Gli repressor (GliR), a process that is also facilitated by Sufu.
GliR enters the nucleus and inhibits the expression of target genes (e.g., Hip1, Gli1, and Ptch1). (B) Hh ligand binds to its receptor,
Ptch, and its coreceptors (e.g., Boc, Cdon, and Gas1), relieving the inhibition of Smo by Ptch. Ptch is internalized and degraded,
and Smo is enriched on the primary cilium. Smo is activated through phosphorylation of its C-terminal tail. This is associated
recruitment of the Sufu-Gli2/3 complexes to the primary cilium and translocation of Kif7 to the cilium tip. Full-length Gli2/3
protein is processed into its activator form (GliA), which enters the nucleus and promotes the expression of target genes.
572 E. Yao, P.-T. Chuangto upregulation of Hh signaling that is associated with
reduced Gli protein levels. This is consistent with Sufu’s
role as a major negative regulator of Hh signaling. Inter-
estingly, maximal Hh signaling in Sufu mutants is not ach-
ieved,37,49 suggesting that Sufu also exerts positive effects
on Hh signaling. This likely results from Sufu regulation of
full-length Gli protein levels (and consequently Gli activa-
tors). In fact, simultaneous perturbation of Gli activators
and repressors in other settings also increases Hh signaling
but compromises maximal Hh signaling. Studies on Sufu
regulation and function will continue to yield key insight
into Hh pathway regulation.
Feedback control of Hh signaling
In addition to signal amplification using a positive feedback
loop, Hh signal transduction also employs negative feedback
to modulate the Hh signal. Both Ptch1 and Hhip are Hh-
binding proteins and are induced by Hh signaling. They can
function to sequester the Hh ligand and alter the dynamicsof Hh signaling.54,55 Interestingly, Boc and Cdon do not
participate in Ptch-mediated feedback regulation since
their expression is downregulated by Hh signaling56 although
Boc/Cdon facilitate Ptch-mediated Hh reception. Because
both signaling strength and duration are important for Hh-
responsive cells,57 feedback control of Hh signaling pro-
vides an important means to fine-tune signaling outputs. It is
conceivable that feedback control could be utilized to
regulate the levels or activity of other Hh pathway compo-
nents. This would confer new properties to Hh signaling.
Modeling would facilitate predictions of properties of Hh
responses but these computational models need to be
tested in an experimental setting both in vitro and in vivo.
Hh pathway components exhibit transcriptional and
post-transcriptional regulations. They are utilized in
different subcellular locales and control different steps of
Hh signaling. A key issue is to assess the contribution of
each type of regulation to essential properties of Hh
signaling such as signal amplification, signal output, and
signal modulation.
Hedgehog signaling in development and disease 573Evolutionary divergence of Hh signaling
While the basic design of the Hh pathway is largely
conserved among diverse species, evolutionary divergence
has occurred, in particular from fly to mammal.58 Gene
duplication has yielded three Hh ligands, two Ptch re-
ceptors, two Kif kinesin proteins, and three Gli tran-
scription factors in mammals. This could have allowed
paralogs to diverge in function and trigger corresponding
changes in their interacting partners. Consistent with this,
Sufu subsumes a central role in negatively regulating Gli
activity while the Fu kinase is dispensable in mammals.
This is in contrast to a central role of Fu in Drosophila Hh
signaling and lack of overt phenotypes in Sufu mutant
flies. The powerful technology of next-generation
sequencing and genome editing (such as CRISPR/Cas) can
be readily applied to diverse organisms. This would open
up a new avenue to test experimentally how various Hh
pathway components and their interactions emerged,
evolved and were even replaced in different species dur-
ing evolution.
The origin of the Hh pathway is unknown. It has been
speculated that it may have evolved from machinery that
senses nutrients.59 This is based on the connection between
lipid metabolism and Hh signaling and the function of ho-
mologs of Hh pathway components in organisms lacking
active Hh signaling and thus predating the Hh pathway.
Again, the ability to manipulate the genome with greater
ease would allow testing of these hypotheses.The primary cilium and vertebrate Hedgehog
signaling
Another unique aspect of vertebrate Hh signaling is the
utilization of the primary cilium for transducing the Hh
signal.60e71 The primary cilium is a microtubule-based,
evolutionarily conserved organelle. Construction of the
cilium relies on intraflagellar transport powered by the
anterograde kinesin and the retrograde dynein motor. Most
vertebrate cells have a single primary cilium. Genetic
analysis of mutants defective in ciliogenesis or ciliary
function provides strong evidence to support an essential
role of the cilium in Hh signal transduction. Consistent with
this model, most core Hh components localize to the cilium
in a dynamic manner.49,72e77
How primary cilia control various steps of Hh signal
transduction is under intensive investigation. A current
model suggests that Sufu is recruited to the cilium via Gli
proteins. Sufu, Gli, and kinesin Kif7 are enriched at the
cilium tip. Sufu-Gli association is proposed to be disrupted
upon Hh stimulation perhaps at the cilium tip, allowing the
production of Gli activators.52,53 Kif7 controls cilium ar-
chitecture at the tip and this could affect Sufu-Gli activ-
ity.78 New tools are needed in order to establish the
function of ciliary localization of Hh pathway components.
The connection between Hh signaling and lipid metabolism
has long fueled the speculation that changes in membrane
lipid contents have an important impact on Hh signaling.
Interestingly, the ciliary membrane seems to contain
specialized lipid composition and may provide a conducive
environment for Hh signal transduction.79,80Noncanonical Hh signaling
Interestingly, several Hh-dependent functions, such as
chemotaxis andpathfinding, appear to be independent of the
primary cilium and Gli-mediated transcription.81 Smo at
different subcellular locales was proposed to account for
eliciting distinct Hh outputs. Smo on the primary cilium re-
lays the Hh signal to Gli proteins, culminating in transcrip-
tional responses whereas Smo outside the cilium regulates
chemotactic responses to Hh. Further studies will shed light
on the adaptation of the primary cilium in Hh signaling.
Hh signaling and congenital anomalies
Studies in model organisms indicate that the Hh pathway
controls key steps of the developmental processes in many
tissues. It is expected that mutations in Hh pathway com-
ponents will lead to human congenital anomalies. Indeed,
mutations in Shh have been detected in human patients
with holoprosencephaly while mutations in Ihh are associ-
ated with brachydactyly and Dhh mutations are found in
gonadal dysgenesis. Disruption of the human Hh acyl-
transferase that catalyzes the transfer of a palmitate
moiety to Hh proteins results in 46, XY Disorder of Sex
Development.82 As next-generation sequencing becomes
more routinely used in clinical diagnosis, it is anticipated
that additional cases of birth defects related to the Hh
pathway will be discovered. Severe loss-of-function muta-
tions in Hh pathway components are likely to cause serious
developmental defects incompatible with life and the fe-
tuses die in utero. In this case, whole genome sequencing
would allow us to determine whether missense mutations
produce milder or unexpected phenotypes in living pa-
tients, which are in general under-diagnosed. These studies
will provide important information on phenotype-genotype
correlations. They will not only assist clinical diagnosis but
also inform us of the function of Hh signaling in human
development. With induced pluripotent stem cell and
genome editing technology, mutations corresponding to
human mutations can be readily created in cell lines and
model organisms to facilitate phenotypic analysis and
mechanistic studies.
Mutations that disrupt ciliary function (ciliopathies) are
associated with a wide range of human syndromes. A
number of disease-causing genes have been identified in
ciliopathy patients. Developmental abnormalities with
hallmarks of Hh phenotypes in these patients are probably
caused by defective Hh signaling. By contrast, it has been
difficult to pinpoint the underlying signaling defects in
other anomalies, particularly dysfunction of postnatal
physiology. In many instances, it is unclear whether and
how disruption of Hh signaling contributes to the pheno-
typic consequences.
Hh signaling and tissue regeneration and repair
Hh signaling has been studied in many adult tissues in the
context of progenitor cells and tissue regeneration and
repair.4 In a number of tissues, active Hh signaling can be
detected in a small population that possesses progenitor
potential, and in many cases Hh signaling is activated upon
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pathway serves to stimulate cell proliferation essential for
tissue repair. For instance, Gli-expressing cells contribute to
the neural stem cell population located in the subventricular
zone of the lateral ventricles and in the subgranular zone of
the hippocampal dentate gyrus in the murine nervous sys-
tem.83 Amajor challenge is to establish the functional role of
Hh signaling in tissue regeneration in a given tissue. In many
instances, it is difficult to unambiguously identify Hh-
producing and -responsive cells in adult tissues in homeo-
stasis and following injury. Tools are generally not available
to eliminate these cell populations exclusively and effi-
ciently in adults in order to evaluate the effects of perturbed
Hh signaling. Moreover, Hh signaling probably interacts with
other pathways in the process of tissue repair. Dissecting the
signaling cascade and crosstalk and assessing the contribu-
tion of Hh signaling in a given tissue is a major effort.Hh signaling and tumor development
Perturbation of Hh signaling is associated with several
human cancers, notably basal cell carcinoma (BCC) and
medulloblastoma. Mutations in Ptch1 are found in most
human BCCs, suggesting that enhanced Hh signaling prob-
ably causes BCC. While it is not possible to establish
definitively a causal relationship between mutations in Hh
components and human cancers, studies in mice and cell
lines have provided strong evidence to support Hh pathway
disruption as a major factor in developing human BCC and a
subset of medulloblastomas. Several other types of human
cancers such as digestive tract tumors have also been
associated with perturbed Hh signaling.84,85 Even if muta-
tions in Hh components are not required for tumor initia-
tion, it remains possible that these tumors utilize the Hh
pathway for growth or survival at certain stages of tumor
development. Next-generation sequencing will continue to
provide important information on Hh signaling and human
cancers, in particular, in uncovering the spectrum of can-
cers that relies on Hh signaling.
Strikingly, molecules that inhibit Smo activity have been
shown to be effective in treating patients with invasive BCC
or medulloblastoma related to Hh pathway overactivity.86,87
Smo appears to be a very druggable target in the Hh pathway
and various Smo inhibitors (such as GDC-0449) have been
developed. This illustrates the feasibility of targeting the Hh
pathway for treating diseases caused by aberrant Hh
signaling. Patients who received GDC-0449 (Vismodegib,
Genentech Inc., South San Francisco, CA, USA) treatment
initially responded but eventually developed resistance.
Genomic analysis, in some cases, revealed mutations in Smo
that conferred resistance to GDC-0449.88 This problem is
common in targeted therapies and effective approaches
that overcome resistance will serve as a paradigm for un-
derstanding drug resistance in targeted therapies. Apart
from its immediate side effects, Smo antagonists can inhibit
bone growth in animal studies89 presumably related to Hh
function in tissue homeostasis and regeneration/repair. This
raises the important question of how long-term use of Hh
inhibitors can disturb normal physiology.
Molecules that target other Hh pathway components
such as Gli have also been reported.90 Efforts to developdrugs against other Hh players are underway. In addition to
offering tools to probe the mechanisms of Hh signaling,
they could provide potential therapies for Hh-related tu-
mors or diseases.
As discussed above, Hh signaling may be utilized at one
stage of tumor development for their growth in tumor types
other than the well-characterized, Hh-related tumors. In
this scenario, the blockade of Hh signaling in combination
with chemotherapeutic drugs would still confer therapeutic
benefits.
Given tissue complexity, tumors derived from different
germ layers seem to respond differently to small molecules
that perturb Hh signaling. The aforementioned Smo an-
tagonists reduce the growth of basal cell carcinoma and
medulloblastoma, indicating a critical role of Hh signaling
in promoting tumor growth. By contrast, Hh agonists cause
stromal hyperplasia in the pancreas and subsequently
inhibit epithelial growth.91 Moreover, genetic ablation of
Hh responses in murine models can accelerate tumor
development in the pancreas or bladder.91,92 This suggests
that Hh pathway activation could slow tumor development
in these cases. These seemingly paradoxical outcomes stem
from complex tissue interactions. Nevertheless, they can
be understood on the basis of the proliferative effect of Hh
signaling and activation of other signaling pathways in a
particular tissue.Acknowledgments
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